Evidence map›Paper›PMID 31604244›Full record

ArticleScience (New York, N.Y.)2019

Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility.

International Multiple Sclerosis Genetics Consortium

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 866 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
866citing papers in PubMed, 7 pooled it
53.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

866 citing papers in PubMed, 7 syntheses or guidelines pooled it, 1,377 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Shared genetic architecture between DTI-ALPS traits and neurodegenerative diseases.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  20. Article

806 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 7 institutions in 4 countries.

International Multiple Sclerosis Genetics Consortium
Inserm · FRInstitut du Cerveau · FRMax Planck Institute of Psychiatry · DENational and Kapodistrian University of Athens · GRUniversité Clermont Auvergne · FRUniversity of California, San Francisco · USYale University · US

Funding

Vascular factors, physical activity, and inflammation as modulators of neurodegenerative and cognitive trajectories (Project 2)P01AG036694 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Rebecca E Amariglio · 2010 to 2026
$50.2M
A Haplotype Map for Multiple SclerosisR01NS049477 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAUSER, STEPHEN L · 2005 to 2014
$15.3M
The Role of B cells in the Origin and Progression of Multiple SclerosisR35NS111644 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEPHEN L HAUSER · 2019 to 2026
$9.1M
Gene Expression and Regulatory Networks in Human LeukocytesRC2GM093080 · NIGMS · HARVARD MEDICAL SCHOOL · PI BENOIST, CHRISTOPHE O., MATHIS, DIANE J · 2009 to 2010
$7.3M
GENE LINKAGE STUDY OF MULTIPLE SCLEROSIS SIBLING PAIRSR01NS026799 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAUSER, STEPHEN L, OKSENBERG, JORGE R. · 1989 to 2018
$6.8M
Genetic and Phenotypic Analysis of Multiple Sclerosis in HispanicsR01NS096212 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI MCCAULEY, JACOB L · 2016 to 2021
$3.1M
Exploring the Role of the Brain Transcriptome in Cognitive DeclineR01AG036836 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI DE JAGER, PHILIP L · 2011 to 2014
$2.9M
Post GWAS approach to identify cell-specific genetic pathways underlying MS riskR01NS088155 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BARANZINI, SERGIO E · 2014 to 2018
$2.2M
Immunogenetic Studies of Autoimmune DiseaseR01AI059829 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI BARCELLOS, LISA F · 2004 to 2008
$1.9M
Medical Research Council G1100125NIAID NIH HHS R01 AI059829NIA NIH HHS P01 AG036694NIA NIH HHS R01 AG036836NIGMS NIH HHS RC2 GM093080NINDS NIH HHS R01 NS026799NINDS NIH HHS R01 NS049477NINDS NIH HHS R01 NS088155NINDS NIH HHS R01 NS096212NINDS NIH HHS R35 NS111644Wellcome Trust
6 · The paper itself

Abstract

We analyzed genetic data of 47,429 multiple sclerosis (MS) and 68,374 control subjects and established a reference map of the genetic architecture of MS that includes 200 autosomal susceptibility variants outside the major histocompatibility complex (MHC), one chromosome X variant, and 32 variants within the extended MHC. We used an ensemble of methods to prioritize 551 putative susceptibility genes that implicate multiple innate and adaptive pathways distributed across the cellular components of the immune system. Using expression profiles from purified human microglia, we observed enrichment for MS genes in these brain-resident immune cells, suggesting that these may have a role in targeting an autoimmune process to the central nervous system, although MS is most likely initially triggered by perturbation of peripheral immune responses.

Indexed as

Chromosome MappingGenome-Wide Association StudyCase-Control StudiesCell Cycle ProteinsChromosomes, Human, XGene FrequencyGenetic LociGenomicsGTPase-Activating ProteinsHumansInheritance PatternsMajor Histocompatibility ComplexMicrogliaMultiple SclerosisPolymorphism, Single NucleotideQuantitative Trait LociCell Cycle ProteinsEVI5 protein, humanGTPase-Activating Proteins

Identifiers

PMID31604244
PMCPMC7241648
OpenAlexW2981477552

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.